- Home
- CSTL vs OLP Comparison
CSTL vs OLP Comparison
Compare CSTL & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- OLP
- Stock Information
- Founded
- CSTL 2007
- OLP 1982
- Country
- CSTL United States
- OLP United States
- Employees
- CSTL N/A
- OLP N/A
- Industry
- CSTL Medical Specialities
- OLP Real Estate Investment Trusts
- Sector
- CSTL Health Care
- OLP Real Estate
- Exchange
- CSTL Nasdaq
- OLP Nasdaq
- Market Cap
- CSTL 576.3M
- OLP 569.9M
- IPO Year
- CSTL 2019
- OLP N/A
- Fundamental
- Price
- CSTL $19.78
- OLP $26.50
- Analyst Decision
- CSTL Strong Buy
- OLP Strong Buy
- Analyst Count
- CSTL 6
- OLP 1
- Target Price
- CSTL $40.00
- OLP $28.00
- AVG Volume (30 Days)
- CSTL 403.1K
- OLP 73.5K
- Earning Date
- CSTL 05-01-2025
- OLP 03-05-2025
- Dividend Yield
- CSTL N/A
- OLP 6.86%
- EPS Growth
- CSTL N/A
- OLP 1.45
- EPS
- CSTL 0.62
- OLP 1.40
- Revenue
- CSTL $332,069,000.00
- OLP $90,456,000.00
- Revenue This Year
- CSTL N/A
- OLP $4.55
- Revenue Next Year
- CSTL $6.01
- OLP $4.51
- P/E Ratio
- CSTL $32.29
- OLP $18.76
- Revenue Growth
- CSTL 51.09
- OLP 0.80
- 52 Week Low
- CSTL $16.97
- OLP $21.11
- 52 Week High
- CSTL $35.84
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- CSTL 36.62
- OLP 52.28
- Support Level
- CSTL $19.22
- OLP $25.70
- Resistance Level
- CSTL $20.30
- OLP $26.86
- Average True Range (ATR)
- CSTL 0.81
- OLP 0.61
- MACD
- CSTL 0.23
- OLP -0.02
- Stochastic Oscillator
- CSTL 43.33
- OLP 61.15
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.